The PALB2 p.G998E variant in this patient was reported at a similar frequency of ~ 10% in a population of BRCA1- and BRCA2-negative male breast cancer patients in Northern Italy as was observed in healthy individuals [56]. This evidence concerns the gene BRCA1 and breast carcinoma.